Exenatide Uses
Links shared publicly online about this topic
FDA approves exenatide for use with insulin glargine
endocrinetoday.com — “The FDA has approved the use of exenatide as an add-on therapy to insulin glargine, with or without metformin or thiazolidinedione, in conjuncti” View full resource at endocrinetoday.com
Most Recently Shared on October 20, 2011 at 9:08 pm By:
#FDA approves exenatide for use with #insulin glargine http://t.co/RenCcpSr
FDA approved expanded indication for exenatide
endocrinetoday.com — “The FDA has approved exenatide injection for use as monotherapy along with diet and exercise to improve glycemic control in adults with type 2 d” View full resource at endocrinetoday.com
Most Recently Shared on November 3, 2009 at 6:06 pm By:
#FDA approved expanded indication for exenatide http://ow.ly/yVIm
Byetta for Type 2 Diabetes - Exenatide and Diabetes
diabetes.about.com — “Byetta is the first of a new class of drugs available for Type 2 diabetes management. It's not used for Type 1. It's been on the market for about a year. It is meant to be a supplemental drug, used in conjunction with Metformin or sulfonylureas or a combination of both to help improve glycemic control in people who have had trouble maintaining good blood glucose levels.” View full resource at diabetes.about.com
Most Recently Shared on May 29, 2010 at 2:28 pm By:
Byetta: Byetta is the first of a new class of drugs available for Type 2 diabetes management. It's not used for Ty... http://bit.ly/dgZEkR
Use of Twice-Daily Exenatide in Basal Insulin--Treated Patients With Type 2 Diabetes --" Ann Intern Med
annals.org — “Use of Twice-Daily Exenatide in Basal Insulin--Treated Patients With Type 2 Diabetes --" Ann Intern Med” View full resource at annals.org
Most Recently Shared on January 22, 2011 at 6:45 am By:
Yvo Sijpkens MD Physician, Doctor, Internist, and Nephrologist
Use of Twice-Daily Exenatide in Basal Insulin-Treated Patients With Type 2 #Diabetes: A RCT: http://bit.ly/huINQI
Use of Twice-Daily Exenatide in Basal Insulin--Treated Patients With Type 2 Diabetes --" Ann Intern Med
annals.org — “Use of Twice-Daily Exenatide in Basal Insulin--Treated Patients With Type 2 Diabetes --" Ann Intern Med” View full resource at annals.org
Most Recently Shared on January 5, 2011 at 9:06 pm By:
Use of Twice-Daily Exenatide in Basal Insulin–Treated Patients With Type 2 Diabetes (Annals of Internal Medicine) http://bit.ly/dHf5CK
MedWire News - Diabetes - DURATION-2 and -3 results support use of once-weekly exenatide
medwire-news.md — “MedWire News Study findings indicate that once-weekly exenatide is a good option for add-on therapy in patients with Type 2 diabetes for whom hypoglycemia, weight loss, and convenience are concerns, say researchers. MedWire News” View full resource at medwire-news.md
Most Recently Shared on July 6, 2010 at 4:16 pm By:
DURATION-2 and -3 results support use of once-weekly exenatide http://tinyurl.com/3xw5fdo #diabetes
EXENATIDE LEADS TO REDUCTION IN LIVER ENZYMES IN DIABETICS INDEPENDENT OF WEIGHT LOSS
diabetesincontrol.com — “I just got back from the AACE Annual sessions in Orlando. It was great to see a lot of you and appreciated the nice comments you had about our newsletter. I did not have a lot of time to put together an overview for out deadline but did want to share an abstract of interest. Deepti Bulchandani, MD and his colleagues have looked at Exenatide for the treatment of elevated enzymes in Non alcoholic fatty liver disease. This is another possible reason to start your patients on Exenatide. Click here t” View full resource at diabetesincontrol.com
Most Recently Shared on May 3, 2010 at 9:22 pm By:
Exenatide use can lead to reduction in liver enzymes in diabetics independent of weight loss. http://bit.ly/aok3gA
BMC Clinical Pharmacology | Abstract | Effect of exenatide on the pharmacokinetics of a combination oral contraceptive in healthy women: an open-label, randomised, crossover trial
biomedcentral.com — “Consistent with its effect on gastric emptying, exenatide, an injectable treatment for type 2 diabetes, may slow the absorption rate of concomitantly administered oral drugs resulting in a decrease in maximum concentration (Cmax). This study evaluated the drug interaction potential of exenatide when administered adjunctively with oral contraceptives, given their potential concomitant use.” View full resource at biomedcentral.com
Most Recently Shared on March 20, 2012 at 9:35 pm By:
Effect of exenatide on the pharmacokinetics of a combination oral contraceptive http://t.co/NtAJ9ZIb
Byetta Approved for Expanded Use as First-Line Treatment for Type 2 Diabetes
drugs.com — “Byetta (exenatide) is used to treat type 2 diabetes. Includes Byetta side effects, interactions and indications.” View full resource at drugs.com
Most Recently Shared on November 3, 2009 at 12:18 am By:
Byetta Approved for Expanded Use as First-Line Treatment for Type 2 Diabetes - http://bit.ly/q10EZ
BYETTA Approved For Expanded Use As First-Line Treatment For Type 2 Diabetes
medicalnewstoday.com — “Amylin pharmaceuticals, inc., (nasdaq: amln) and eli lilly and company (nyse: lly) announced that the u.s. food and drug administration (fda) has approved an expanded indication for byetta® (” View full resource at medicalnewstoday.com
Most Recently Shared on October 31, 2009 at 12:12 pm By:
MNT Clinical Trials Health News
BYETTA Approved For Expanded Use As First-Line Treatment For Type 2 Diabetes: Amylin Pharmaceuticals, Inc., (Na.. http://bit.ly/FO6jd
European Commission grants marketing authorization for use of BYETTA with basal insulin
news-medical.net — “Amylin Pharmaceuticals, Inc. and Eli Lilly and Company announced today that the European Commission has granted marketing authorization to BYETTA (exenatide twice-daily) as an adjunctive therapy to basal insulin, with or without metformin and/or Actos (pioglitazone), for the treatment of type 2 diabetes in adults who have not achieved adequate glycemic control with these agents.” View full resource at news-medical.net
Most Recently Shared on March 23, 2012 at 1:57 pm By:
European Commission grants marketing authorization for use of BYETTA with basal insulin: Amylin Pharmaceuticals,... http://t.co/3EqmxLdM
Expanded approval for Byetta; but also renal warning
theheart.org — “The FDA has issued a warning about exenatide the same day the agency approved its first-line use along with diet and exercise to improve glycemic control in patients with type 2 diabetes mellitus.” View full resource at theheart.org
Most Recently Shared on November 3, 2009 at 6:41 pm By:
heartwire: FDA expands exenatide use; warns of renal-failure risk http://bit.ly/O9Drq
FDA: Byetta Label Revised to Include Safety Information on Possible Kidney Problems
fda.gov — “The U.S. Food and Drug Administration today acted on new safety information about possible kidney function problems, including kidney failure, in patients taking Byetta (exenatide), a drug used to treat Type 2 diabetes.” View full resource at fda.gov
Most Recently Shared on November 2, 2009 at 8:19 pm By:
FDA: Byetta Label Revised to Include Safety Information on Possible Kidney Problems. Read the press release here: http://tinyurl.com/yfmgmf9
Study Highlights Incidence of Cardiovascular Disease-Related Events and All-Cause Hospitalizations Associated With Byetta Compared to Insulin, Thiazolidinediones, Sulfonylureas, Metformin and Januvia - Drugs.com MedNews
drugs.com — “Retrospective Study of Nearly 375,000 Type 2 Diabetes Patients Presented at American Heart Association 2010 Scientific Sessions Amylin Pharmaceuticals, Inc. (Na” View full resource at drugs.com
Most Recently Shared on November 17, 2010 at 6:28 pm By:
Drugs and Devices OW OW Health
Study Highlights Incidence of Cardiovascular Disease-Related Events and All-Cause Hospitalizations Associa... http://bit.ly/bXIAL9 #drug
FDA Issues Warning for Diabetes Drug - myOptumHealth
myoptumhealth.com — “Read the news article FDA Issues Warning for Diabetes Drug at www.myOptumHealth.com” View full resource at myoptumhealth.com
Most Recently Shared on November 3, 2009 at 9:37 pm By:
FDA Issues Warning for Diabetes Drug: Reports of kidney problems for those using Byetta prompted action http://bit.ly/1aRJ1R
The Top 3 resources shared on this topic. More resources.
Key stats and trends about this topic
Featuring the top 3 experts for this topic
-
Endocrine Today
The official Twitter for Endocrine Today, clinical news on diabetes and endocrine disorders.
-
Endocrine Today
The official Twitter for Endocrine Today, clinical news on diabetes and endocrine disorders.
-
Diabetes, Type 2
Organizing type 2 diabetes resources shared by health experts, advocates, and organizations into WisdomCards.
Advertisement
